JC
Jun Chen
Southern University of Science and Technology, Central South University
Research areas: Medicine · Hepatology · Drug-Induced Hepatotoxicity and Protection · Hepatocellular Carcinoma Treatment and Prognosis · Hepatitis B Virus Studies
Employment
Education
Projects & Funding
-
Shenzhen Sanming Project Shenzhen Health Committee2016 - Present
Publications (37)
- Clinical implications of discordant FIB-4 and LSM in MASLD: Integrating evidence and optimizing pathways: Letter to the editor on “Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and di… Save
- Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis Save
- Serum Bile Acid Profiling Across the Full Spectrum of HBV-Related Liver Diseases in Chinese Population: Implications for Diagnosis and Treatment Assessment Save
- Global Trends and Health Inequalities in Acute Hepatitis E Burden: A Joinpoint Regression and Cross‐Country Inequality Analysis, 1990–2021 Save
- Creatinine-to-cystatin C ratio and all-cause and cardiovascular mortality in U.S. adults with nonalcoholic fatty liver disease: a nationwide cohort study Save
- Global Trends and Cross-country Inequalities of Acute Hepatitis E in the Elderly, 1990–2021: A Comprehensive Analysis Save
- Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective Save
- Rapid diagnosis of Mycoplasma pneumoniae and prediction of antibiotic resistance by nanopore adaptive sampling Save
- Global temporal trends and projections of acute hepatitis E incidence among women of childbearing age: Age-period-cohort analysis 2021 Save
- Drug-induced liver injury in children: A nationwide cohort study from China Save
- Constructing an immune-related prognostic signature for predicting prognosis and immune response in hepatocellular carcinoma Save
- Inverse relationship between HBV DNA levels and liver histopathological changes in immune‐tolerant CHB patients Save
- Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase Save
- Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update Save
- Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels Save
- Inhibition of HSPA8 by rifampicin contributes to ferroptosis via enhancing autophagy Save
- Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug‐induced liver injury: A multicenter, randomized, phase <scp>II</scp> trial Save
- Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury Save
- Global Quantification of Glutathione S-Transferases in Human Serum Using LC-MS/MS Coupled with Affinity Enrichment Save
- Acute Kidney Injury and Early Predictive Factors in COVID-19 Patients Save